ENTRY       D08776                      Drug
NAME        Pneumococcal vaccine polyvalent;
            Pneumococcus vaccine;
            Pneumovax 23 (TN)
PRODUCT     PNEUMOVAX 23 (Merck Sharp & Dohme LLC)
REMARK      Therapeutic category: 6311
            ATC code: J07AL01
            Product: D08776<JP/US>
EFFICACY    Active immunization (pneumococcal)
  DISEASE   Prevention of pneumococcal disease [DS:H01321]
COMMENT     23 serotypes contained in the vaccine (1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 23F, and 33F)
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J07 VACCINES
               J07A BACTERIAL VACCINES
                J07AL Pneumococcal vaccines
                 J07AL01 Pneumococcus, purified polysaccharides antigen
                  D08776  Pneumococcal vaccine polyvalent &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Immunological Agents
              Vaccines
               Pneumococcal
                Pneumococcal Polysaccharide Vaccine, 23 Valent
                 D08776  Pneumococcal vaccine polyvalent
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              63  Biological preparations
               631  Vaccines
                6311  Bacterial vaccines
                 D08776  Pneumococcal vaccine polyvalent
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D08776
DBLINKS     PubChem: 96025459
///
